Angiocentric glioma

MONDO:0016705

Angiocentric glioma (AG) is an extremely rare slow-growing glial neoplasm of the central nervous system, usually arising in a superficial location in the cerebrum, affecting all ages and both sexes, and characterized by intractable seizures and headaches, with most cases being cured by surgical incision alone and therefore having a good prognosis.

Also known as: Monomorphus angiocentric glioma, angiocentric glioma (WHO grade I), angiocentric neuroepithelial tumor, angiocentric neuroepithelial tumour, ANGL

1454 clinical trials for this condition and its sub-types, 1 tagged with Angiocentric glioma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Low grade glioma (268)

Including sub-types (1454) Tagged with Angiocentric glioma (1)

Not yet finished but already full! 1

Kids' brain tumor drugs tested for Long-Term safety

Disease control Ongoing

This study follows 165 children who previously took dabrafenib and/or trametinib for certain brain tumors. Researchers want to see if these drugs are safe over the long term and how they affect growth. The children continue their treatment and are monitored for side effects and d…

Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC

Angiocentric glioma

Where it sits in the disease tree

Kids' brain tumor drugs tested for Long-Term safety